It looks like you're using an Ad Blocker.

Please white-list or disable AboveTopSecret.com in your ad-blocking tool.

Thank you.

 

Some features of ATS will be disabled while you continue to use an ad-blocker.

 

Medicaid Rip Off's-Huge Lobbying Pay offs-CEO Pay Up 671%-3,000 Workers Laid Off- Epipen-Mylan

page: 1
9

log in

join
share:

posted on Dec, 8 2016 @ 11:45 PM
link   
Heather Bresch CEO of Mylan the parent Co. that make Epipen is a real piece of work.
She has really enjoyed the fruits of her labor. Raising the epipen price 400% and getting a hearty 671% raise while the people who use the epipen struggle to pay for it.
Oh then of course there is the fact that the epipen was mis-classified. This lead to a 456,000,000$ fine, for milking medicaid.
Then there is the lobbying, in 2008, Mylan was reportedly spending $270,000 on lobbying then it shot up to $1.2 million. Nice.

Generic drug maker is canning 10% of it's work force. Restructuring to integrate acquisitions. Mylan is under investigations for medicaid issues and has almost a half a billion $ in fines.


Generic drugmaker Mylan, which has been under fire for price hikes on the life-saving EpiPen allergy treatment, said on Wednesday that it expected to cut less than 10 percent of its workforce in a restructuring to integrate acquisitions.

Mylan, whose shares were down more than 3 percent in mid-afternoon trading, has been under investigation by the U.S. government, and its chief executive officer was called before Congress to testify on raising the price of a pair of EpiPens to more than $600 from $100 in 2008.

After Mylan acquired EpiPen the company also amped up its lobbying efforts. In 2008, its reported spending on lobbying went from $270,000 to $1.2 million,


OOps 456,000,000$ fine because their drug was classified wrong so they could charge more, What???


The company said in October that it would pay $465 million to settle questions on the impact of the classification on U.S. government healthcare costs.


Mylan CEO's Pay Rose Over 600 Percent as EpiPen Price Rose 400 Percent.
Heather Bresch seems to have found a sweet little company to run into the ground. And if she gets fired, I'm sure she has a huge firing bonus, in the millions.


Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.

After Mylan acquired EpiPen the company also amped up its lobbying efforts. In 2008, its reported spending on lobbying went from $270,000 to $1.2 million,



www.nbcnews.com...
www.nbcnews.com...




posted on Dec, 9 2016 @ 08:13 AM
link   
a reply to: seasonal

How much is too much pay? Then to lay of people?



new topics
 
9

log in

join